RecruitingPhase 3NCT05075161

Pirfenidone to Prevent Fibrosis in Ards.

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Università Vita-Salute San Raffaele
Principal Investigator
Giovanni Landoni, Professor
Vita-Salute San Raffaele University
Intervention
Pirfenidone(drug)
Enrollment
130 enrolled
Eligibility
18 years · All sexes
Timeline
20222025

Study locations (17)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05075161 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials